• 1
    Evans D, Howard E, Giblin C, et al.Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A2010; 152A: 32732.
  • 2
    Hyman S, Shores A, North K. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology2005; 65: 103744.
  • 3
    Galbaud du Fort G, Newman S, Bland R. Psychiatric comorbidity and treatment seeking: sources of selection bias in the study of clinical populations. J Nerv Ment Dis1993; 181: 46774.
  • 4
    Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biomet Bull1946; 2: 4753.
  • 5
    Samuelsson B, Riccardi V. Neurofibromatosis in Gothenburg, Sweden. III. Psychiatric and social aspects. Neurofibromatosis1989; 2: 84106.
  • 6
    Dilts C, Carey J, Kircher J, et al.Children and adolescents with neurofibromatosis1: a behavioral phenotype. J Dev Behav Pediatr1996; 17: 22939.
  • 7
    Johnson N, Saal H, Lovell A, Schorry E. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr1999; 134: 76772.
  • 8
    Johnson H, Wiggs L, Stores G, Huson S. Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol2005; 47: 23742.
  • 9
    Hofman K, Harris E, Bryan R, Denckla M. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr1994; 128: S18.
  • 10
    Coude F, Mignot C, Lyonnet S, Munnich A. Early grade repetition and inattention associated with neurofibromatosis type 1. J Atten Disord2007; 11: 1015.
  • 11
    Ford T, Goodman R, Meltzer H. Service use over 18 months among a nationally representative sample of children with psychiatric disorder. Clin Child Psychol Psychiatry2003; 8: 3751.
  • 12
    Mautner V, Kluwe L, Thakker S, Leark R. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol2002; 44: 16470.
  • 13
    World Health Organization. Mental Disorders: A Glossary and Guide to their Classification in Accordance with the 10th Revision of the International Classification of Diseases: Research Diagnostic Criteria (ICD-10). Geneva: World Health Organization, 1993.
  • 14
    Mouridsen S, Andersen L, Sörensen S, Rich B, Isager T. Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatr1992; 55: 158.
  • 15
    Gaffney G, Tsai L. Magnetic resonance imaging of high level autism. J Autism Dev Disord1987; 17: 4338.
  • 16
    Baird G, Simonoff E, Pickles A, et al.Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet2006; 15: 2105.
  • 17
    Gillberg C, Forsell C. Childhood psychosis and neurofibromatosis – more than a coincidence?J Autism Dev Disord1984; 14: 18.
  • 18
    Fombonne E, du Mazaubrun C, Cans C, Grandjean H. Autism and associated medical disorders in a large French epidemiological sample. J Am Acad Child Adolesc Psychiatry1997; 36: 15619.
  • 19
    Barton B, North K. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol2004; 46: 55363.
  • 20
    Noll R, Reiter-Purtill J, Moore B, et al.Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A2007; 143A: 226173.
  • 21
    Huijbregts S, Jahja R, De Sonneville L, De Breij S, Swaab-Barneveld H. Social information processing in children and adolescents with neurofibromatosis type 1. Dev Med Child Neurol2010; 52: 6205.
  • 22
    Huijbregts S, de Sonneville L. Does cognitive impairment explain behavioural and social problems of children with neurofibromatosis type 1?Behav Genet2011; 41: 4306.
  • 23
    Evans DG, O’Hara C, Wilding A, et al.Mortality in neurofibromatosis 1 in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet2011; 19: 118791.
  • 24
    National Institutes of Health Consensus Development Conference. Neurofibromatosis conference statement. Arch Neurol1988; 45: 5758.
  • 25
    Riccardi V. Neurofibromatosis: Phenotype, Natural History and Pathogenesis, 2nd edn. Baltimore, MD: Johns Hopkins University Press, 1992.
  • 26
    Constantino J. The Social Responsiveness Scale. Los Angeles, CA: Western Psychological Services, 2002.
  • 27
    Constantino J, Davis S, Todd R, et al.Validation of a brief quantitative measure of autistic traits: comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised. J Autism Dev Disord2003; 33: 42733.
  • 28
    Conners K, Sitarenios G, Parker J, Epstein J. The Revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol1998; 26: 25768.
  • 29
    Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry1997; 38: 5816.
  • 30
    Goodman R, Gatward R. Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Br J Psychiatry2000; 177: 5349.
  • 31
    Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English Indices of Deprivation 2007. London: Communities and Local Government, 2008.
  • 32
    Matson JL, Shoemaker M. Intellectual disability and its relationship to autism spectrum disorders. Res Dev Disabil2009; 30: 110714.
  • 33
    La Malfa G, Lassi S, Bertelli M, Salvini R, Placidi GF. Autism and intellectual disability: a study of prevalence on a sample of the Italian population. J Intellect Disabil Res2004; 48(Pt 3): 2627.
  • 34
    Achenbach T, McConaughy S, Howell C. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull1987; 101: 21332.
  • 35
    Caron C, Rutter M. Comorbidity in child psychopathology: concepts, issues and research strategies. J Child Psychol Psychiatry1991; 32: 106380.
  • 36
    Angold A, Costello J, Erkanli A. Comorbidity. J Child Psychol Psychiatry1999; 40: 5787.
  • 37
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4th edn text revision. Washington, DC: American Psychiatric Association, 2000.
  • 38
    Brereton A, Tonge B, Einfeld S. Psychopathology in children and adolescents with autism compared to young people with intellectual disability. J Autism Dev Disord2006; 36: 86370.
  • 39
    Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry2008; 47: 9219.
  • 40
    International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Med Genet2001; 69: 57081.
  • 41
    Marui T, Hashimoto O, Nanba E, et al.Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population. Am J Med Genet2004; 131B: 437.
  • 42
    Mbarek O, Marouillat S, Martineau J, Barthélémy C, Müh J, Andres C. Association study of the NF1 gene and autistic disorder. Am J Med Genet1999; 88: 72932.
  • 43
    Constantino JN, Todd RD. Autistic traits in the general population: a twin study. Arch Gen Psychiatry2003; 60: 52430.
  • 44
    Kadesjo B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry2001; 42: 48792.